These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18798067)

  • 21. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
    Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
    Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible relationship between the resistin gene C-420G polymorphism and colorectal cancer in a Turkish population.
    Düzköylü Y; Arıkan S; Turan S; Yaylım İ; Doğan MB; Sarı S; Ersöz F; Zeybek Ü; Tımırcı Kahraman Ö; Çelikel B; Erdem S
    Turk J Gastroenterol; 2015 Sep; 26(5):392-6. PubMed ID: 26215065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
    Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
    Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
    Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
    Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
    Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rs1862513 promoter variant of resistin gene influences susceptibility to nonalcoholic fatty liver disease.
    Nouri S; Navari M; Shafiee R; Mahmoudi T; Rezamand G; Asadi A; Nobakht H; Dabiri R; Farahani H; Tabaeian SP
    Rev Assoc Med Bras (1992); 2024; 70(7):e20231537. PubMed ID: 39045929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of thymidine phosphorylase in primary colorectal cancer and liver metastasis-relationship between mRNA levels in cancer cells and protein levels in cancerous tissue].
    Ishibashi K; Sobajima J; Ishiguro T; Okada N; Miyazaki T; Yokoyama M; Ishida H
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):425-9. PubMed ID: 19295266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of Polymorphisms of Resistin Gene Promoter -420C/G, Glutathione Peroxidase -1 Gene Pro198Leu and Cigarette Smoking in Nonalcoholic Fatty Liver Disease.
    Zhang CX; Guo LK; Qin YM; Li GY
    Chin Med J (Engl); 2015 Sep; 128(18):2467-73. PubMed ID: 26365964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
    Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
    Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease.
    Tang NP; Wang LS; Yang L; Zhou B; Gu HJ; Sun QM; Cong RH; Zhu HJ; Wang B
    Clin Chem Lab Med; 2007; 45(11):1471-5. PubMed ID: 17924842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 and the risk of colorectal cancer.
    Wang MJ; Zhou ZG; Wang L; Yu YY; Zhang P; Zhang Y; Cui CF; Yang L; Li Y; Zhou B; Sun XF
    Oncology; 2009; 76(3):199-204. PubMed ID: 19209010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of Resistin gene expression in peripheral blood mononuclear cell and its gene polymorphism in a small range population.
    Yang YM; Xu ZR; Wu LJ; Huang WD
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):132-5. PubMed ID: 17266189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Goto T; Mizukami H; Kitamura YH; Sakuraba K; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jun; 29(6):2215-7. PubMed ID: 19528483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.